3002.12.00.90/Human Immunoglobulin G (IgG) Concentrate/Canada

Human Immunoglobulin G (IgG) Concentrate from Canada

A purified fraction of human blood plasma containing high levels of Immunoglobulin G antibodies, used therapeutically to treat primary immunodeficiencies and autoimmune disorders. It falls under HTS 3002.12.0090 as an immunological product derived from blood fractions, prepared for therapeutic use via biotechnological purification processes. This excludes simple blood products without specific immunological modification.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Verify FDA biologics license and ensure cold chain documentation (2-8°C) during import to maintain efficacy

• Provide certificates of analysis confirming immunological activity and absence of contaminants like prions

• Avoid misclassification as general plasma; include proof of fractionation process to confirm HTS 3002 placement

Human Immunoglobulin G (IgG) Concentrate from Canada — Import Duty Rate | HTS 3002.12.00.90